Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes

Pre-Administration of Brimonidine in Intravitreal Anti-VEGF Therapy

NCT03513172 ·Status: COMPLETED ·Phase: NA

Brimonidine Eye Drops in the Prevention of Myopia Progression

NCT06996236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma

NCT01105065 ·Status: COMPLETED ·Phase: NA

A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00061529 ·Status: COMPLETED ·Phase: PHASE3

Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

NCT00567411 ·Status: UNKNOWN ·Phase: NA

A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension

NCT01525173 ·Status: COMPLETED ·Phase: PHASE4

Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution

NCT07075224 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT01646151 ·Status: COMPLETED

Pupil Dilation for Treatment of IFIS

NCT03760185 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial

NCT04647461 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%

NCT01297517 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA

NCT05474716 ·Status: COMPLETED ·Phase: PHASE4

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

NCT01863953 ·Status: COMPLETED ·Phase: PHASE2

Effect of Brimonidine on Corneal Thickness

NCT01250236 ·Status: UNKNOWN

Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate

NCT06730516 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

NCT00652483 ·Status: COMPLETED ·Phase: PHASE3

24-hour IOP-lowering Effect of 0.01% Bimatoprost

NCT01271686 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension

NCT00168363 ·Status: COMPLETED ·Phase: PHASE3

Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

NCT01201551 ·Status: COMPLETED ·Phase: NA

The Effect of Lumify™ Eyedrops on Eyelid Position

NCT03782701 ·Status: COMPLETED ·Phase: PHASE4

Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study

NCT04838665 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

NCT01099774 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

NCT02039765 ·Status: COMPLETED ·Phase: PHASE1

A Study of Bimatoprost 0.01% in the Clinical Setting

NCT01814761 ·Status: COMPLETED